Donald Straughan

School of Pharmacy, Chapel Hill, NC, United States 
"Donald Straughan"
Mean distance: 16.08 (cluster 11)
Cross-listing: Chemistry Tree

BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Ireland SJ, Straughan DW, Tyers MB. (1987) Influence of 5-hydroxytryptamine uptake on the apparent 5-hydroxytryptamine antagonist potency of metoclopramide in the rat isolated superior cervical ganglion. British Journal of Pharmacology. 90: 151-60
Bakhle YS, Morton IK, Straughan DW, et al. (1986) Third Report on the Organization of Pharmacology in Great Britain. British Journal of Pharmacology. 87: 463-74
Oakley NR, Jones BJ, Straughan DW. (1984) The benzodiazepine receptor ligand CL218,872 has both anxiolytic and sedative properties in rodents. Neuropharmacology. 23: 797-802
Caulfield MP, Higgins GA, Straughan DW. (1983) Central administration of the muscarinic receptor subtype-selective antagonist pirenzepine selectively impairs passive avoidance learning in the mouse. The Journal of Pharmacy and Pharmacology. 35: 131-2
Caulfield M, Straughan D. (1983) Muscarinic receptors revisited Trends in Neurosciences. 6: 73-75
Caulfield MP, Straughan DW, Cross AJ, et al. (1982) Cortical muscarinic receptor subtypes and Alzheimer's disease. Lancet. 2: 1277
Forrester PA, Straughan DW. (1981) Effect of depressant drugs on ECoG and on glutamate and ACh-excited cortical neurones in rats. Neuropharmacology. 20: 803-11
Mayer ML, Straughan DW. (1981) Effects of 5-hydroxytryptamine on central neurones antagonized by bicuculline and picrotoxin. Neuropharmacology. 20: 347-50
Straughan DW. (1981) The challenge of industrial research: a pharmacologist's view on his move from academe to industry Trends in Pharmacological Sciences. 2: 27-28
Straughan DW, MacLeod NK, James TA, et al. (1980) GABA and the nigrothalamic pathway Brain Research Bulletin. 5: 7-11
See more...